Skip to main content
OpenTrials
Completed

NCT Number: NCT02448186

Intervention Development for Social Stress, Mental Health, and HIV Risk MSM

The proposed study will adapt a cognitive behavioral intervention to support high-risk MSM's adaptive coping with minority stress, alleviate associated depression and anxiety, and reduce HIV risk behavior. The adapted intervention is expected to increase awareness of the unhealthy impact of minority stress; facilitate objective self-schemas in the face of minority stress; and strengthen one's skills and self-efficacy for managing minority stress and associated anxiety and depression to reduce risk for acquiring HIV.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Gay, bisexual, and other men who have sex with men (MSM) are the population most severely affected by HIV in the U.S. and one of the only risk groups in the U.S. for which new infections continue to rise. MSM also experience a vastly disproportionate risk of mental health disorders, especially depression and anxiety. Numerous studies have shown that this mental health disparity arises from the early and ongoing stressors, known as minority stress, that MSM experience related to their sexual orientation. Despite the fact that minority stress is strongly related to anxiety and depression, and that minority stress and related mental health problems synergistically propel HIV risk behaviors, no existing HIV prevention intervention targets minority stress in order to reduce MSM's HIV risk behavior. This project aims to develop a theoretically-driven intervention that reduces the health-depleting effects of minority stress through targeting the basic psychosocial mechanisms linking minority stress to HIV risk behavior. These mechanisms include maladaptive emotion regulation, negative thinking styles, low self-efficacy, avoidance, and impulsivity, which are the very targets of an existing cognitive-behavioral, manualized intervention--the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UPTTED). The UPTTED changes these mechanisms using motivational interviewing, interoceptive and situational exposure, cognitive restructuring, mindfulness, and self-monitoring exercises, all grounded in cognitive-behavioral principles and developmental and affective neuroscience models of stress. The proposed study will adapt the UPTTED to support high-risk MSM's adaptive coping with minority stress, alleviate associated depression and anxiety, and reduce HIV risk behavior. The adapted UPTTED is expected to increase awareness of the unhealthy impact of minority stress; facilitate objective self-schemas in the face of minority stress; and strengthen one's skills and self-efficacy for managing minority stress and associated anxiety and depression to reduce risk for acquiring HIV. MSM who have experienced minority stress, mental health problems, and HIV risk behavior in the previous 3 months (n = 30) and community health experts (n = 30) will provide suggestions for adaptations to the existing intervention manual, including culturally relevant vignettes, examples, and exercises for adaptively responding to minority stress and managing HIV risk. The feasibility, acceptability, and preliminary efficacy of the adapted intervention will then be tested in a randomized waitlist controlled trial with MSM (n = 60) who report recent experiences with minority stress, depression and anxiety, and HIV risk behavior. The primary outcome will be HIV risk behavior. Secondary outcomes will be reductions in mediators including depression, anxiety, and the mechanisms of the conceptual model. This project innovatively seeks to test the preliminary efficacy of the first theoretically-driven intervention targeting the mental and sexual health consequences of minority stress and does so by targeting the underlying mechanisms that powerfully drive these simultaneous health threats.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjective stress related to sexual identity over the previous three months;
  • Symptoms of depression or anxiety within the past three months;
  • HIV sexual risk behavior (one or more acts of condomless insertive or receptive anal sex with a male partner of unknown or discordant serostatus) within the past three months;
  • Biological male gender;
  • At least 18 years of age;
  • Not known to have HIV;
  • Residential stability and availability for six months;
  • Ability to communicate in English; and
  • Provision of informed consent.

Exclusion criteria

  • active, unmedicated symptoms of bipolar I or bipolar II disorder or any Diagnostic and Statistical Manual-IV psychotic disorder in the past 12 months;
  • Current suicidal or homicidal ideation;
  • Evidence of gross cognitive impairment;
  • Current enrollment in an HIV-related intervention or research study; and
  • Knowledge of being infected with HIV.

Treatment and study plan

ESTEEM

Behavioral

10-session cognitive behavioral treatment

Primary outcomes

  1. reductions in the number of condomless anal sex acts in the past 90 days with HIV-positive or HIV-status-unknown male partners

    Time frame: 3 months

Secondary outcomes

  1. reduction in depression severity as measured with the Center for Epidemiological Studies Depression Scale

    Time frame: 3 months

  2. reduction in anxiety severity as measured with the Overall Anxiety Severity & Impairment Scale

    Time frame: 3 months

  3. reduction in minority stressors as measured with the Sexual Orientation Concealment Scale

    Time frame: 3 months

  4. reductions in psychological risk factors measured with the Ruminative Responses Scale

    Time frame: 3 months

  5. reductions in number of days in which heavy alcohol and potentially harmful recreational substances were use

    Time frame: 3 months

  6. among individuals with body image disturbance, improvements in body attitudes as measured with the Male Body Attitude Scale

    Time frame: 3 months

  7. among individuals with sexual compulsivity, reduction in sexual compulsivity severity as measured with the Sexual Compulsivity Scale

    Time frame: 3 months

  8. reduction in alcohol use problems as assessed with the Alcohol Use Disorders Identification Test

    Time frame: 3 months

  9. in participants with generalized anxiety disorder, reduction in Penn State Worry Questionnaire

    Time frame: 3 months

  10. reduction in depression severity as measured with the Overall Depression Severity & Impairment Scale

    Time frame: 3 months

  11. reduction in anxiety severity as measured with the State Trait Anxiety Inventory (State subscale)

    Time frame: 3 months

  12. reduction in minority stressors as measured with the Internalized Homophobia Scale

    Time frame: 3 months

  13. reduction in minority stressors as measured with the Rejection Sensitivity Scale

    Time frame: 3 months

  14. reductions in psychological risk factors measured with the Rathus Assertiveness Schedule

    Time frame: 3 months

  15. reductions in psychological risk factors measured with the Difficulties of Emotion Regulation Scale

    Time frame: 3 months

  16. reductions in psychological risk factors measured with the Multidimensional Scale of Perceived Social Support

    Time frame: 3 months

  17. in participants with obsessive-compulsive disorder, reductions in the Yale-Brown OC Scale

    Time frame: 3 months

  18. in participants with panic disorder, reduction in the Panic Disorder Severity Scale

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Hunter College of City University of New York

Registry information

Official study title

Intervention Development for Social Stress, Mental Health, and HIV Risk Among MSM

Acronym: ESTEEM

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
May 19, 2015
Registry last updated
May 19, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.